Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Get Alerts ENOV Hot Sheet
Join SI Premium – FREE
Wilmington, DE, March 28, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV) ("Enovis" or the "Company"), an innovation-driven, medical technology growth company, today announced that management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference. The presentation is scheduled to begin at 3:45 p.m. Eastern Time on Tuesday, April 9, 2024.
A link to the live audio webcast, as well as a replay of this event, will be available on the Company’s website under the Investors tab at Events and Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
+1-917-734-7450
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Luke Wilson Presides Over Fanatics’ “Town Hall,” a Season-Long NFL Campaign Highlighting the Fanatics App and Benefits of FanCash
- Pillar Biosciences and Hamilton Expand Automated NGS Library Preparation Method for oncoReveal® Nexus 21 Gene Panel on Hamilton Microlab STAR™ and STARlet™ Liquid Handling Systems
- Kristin Peikert Named Chief People Officer of Macmillan Learning
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share